Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | NOS1 | P29475 | 4/20 | 0.34 |
| ▸ | NOS2 | P35228 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3985111 | 0.77 | CHRNB2 (0.45) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL7147030 | 0.76 | CHRNB2 (0.41) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL19922063 | 0.75 | CHRNB2 (0.44) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL1934292 | 0.75 | CHRNB2 (0.47) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL25764949 | 0.75 | CHRNB2 (0.44) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL12105152 | 0.75 | CYP1A2 (0.50) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL3434244 | 0.75 | CHRNB2 (0.44) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL4559420 | 0.73 | CHRNB2 (0.42) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL9327568 | 0.73 | CHRNB2 (0.42) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL7073933 | 0.73 | CHRNB2 (0.40) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029626-A1 | Cyclic sulfones useful as mitochondrial sodium-calcium exchangers | NOVARTIS AG (CH) | 2010-02-04 | — | — | US | claimed |
| CN-109306027-B | Bifunctional photoinitiator and application thereof | 北京英力科技发展有限公司 | 2020-09-01 | — | — | CN | disclosed |
| EP-2935289-B1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM GROUP B V (NL) | 2019-06-26 | — | — | EP | disclosed |
| EP-3459957-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM Group B.V. (NL) | 2019-03-27 | — | — | EP | disclosed |
| EP-3019508-B1 | LIQUID BISACYLPHOSPHINE OXIDE PHOTOINITIATOR | IGM GROUP B V (NL) | 2019-01-30 | — | — | EP | disclosed |
| US-10040810-B2 | Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators | BASF SE (DE) | 2018-08-07 | — | — | US | disclosed |
| EP-2909165-B1 | HYBRID PHOTOINITIATORS | IGM GROUP B V (NL) | 2018-05-30 | — | — | EP | disclosed |
| EP-2459519-B1 | MACROPHOTOINITIATORS | BASF SE (DE) | 2017-11-29 | — | — | EP | disclosed |
| US-9796740-B2 | Liquid bisacylphosphine oxide photoinitiator | BASF SE (DE) | 2017-10-24 | — | — | US | disclosed |
| US-9701762-B2 | Hybrid photoinitiators | BASF SE (DE) | 2017-07-11 | — | — | US | disclosed |
| EP-1353959-A1 | SURFACE-ACTIVE PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2003-10-22 | — | — | EP | disclosed |
| EP-1349877-A1 | SURFACE-ACTIVE PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2003-10-08 | — | — | EP | disclosed |
| EP-1341823-A1 | SURFACE-ACTIVE PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| WO-2003066687-A2 | SURFACE-ACTIVE PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-08-14 | — | — | WO | disclosed |
| EP-1309599-A1 | SURFACE-ACTIVE PHOTOINITIATORS | Ciba SC Holding AG (CH) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002048203-A1 | SURFACE-ACTIVE PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002048202-A1 | SURFACE-ACTIVE PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002048204-A1 | SURFACE-ACTIVE PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002040602-A1 | FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-05-23 | — | — | WO | disclosed |
| WO-2002014326-A1 | SURFACE-ACTIVE PHOTOINITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029626-A1 | Cyclic sulfones useful as mitochondrial sodium-calcium exchangers | SLC8B1, MCU, GLS | CHRNB2 4377/4885CHRNA7 4314/4885CHRNA4 4670/4885 |
| US-10040810-B2 | Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators | ARSA, RER1, ACSL6 | CHRNB2 2018/4885CHRNA7 878/4885CHRNA4 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.